Industry Updates for the Psychedelics World | Page 21 of 35

Psychedelics News

Industry

Finance, Industry

1 Sep 2022

Cathie Wood’s ARK Invest Releases Psychedelic Research Report

Cathie Wood and the ARK Invest team have released a full report on the psychedelic sector and investment landscape....

By Jason Najum

Industry

31 Aug 2022

Mindset Pharma Expands IP Portfolio with Three Next-Gen Psychedelics

Mindset Pharma Further Expands its IP Portfolio with Three Additional Non-Tryptamine Families of Next-Generation Psychedelic Compounds...

By Microdose NewsDesk

Industry

30 Aug 2022

Cybin Doses First Patients in Phase 1/2a Depression trial

Cybin Inc....

By Microdose NewsDesk

Industry, Science

26 Aug 2022

Psychedelic Research Round-Up, by Blossom

Twice a month, our friends from Blossom will update you on the latest in psychedelic research....

By Floris Wolswijk

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry, Science

25 Aug 2022

Anchoring Peak Experience: The World’s First Study of VR and Psychedelics

Virtual Reality and Psychedelics: A new frontier in mind medicine?...

By Emma Stone

Industry

25 Aug 2022

MindMed Doses First Patient in Phase 2b Trial

MindMed Announces First Patient Dosed in Phase 2b Trial of MM-120 in Generalized Anxiety Disorder...

By Microdose NewsDesk

Industry

24 Aug 2022

A Look at GH Research’s Financial and Business Results

GH Research owns the title of the most low-key player in the psychedelic medicine space....

By Jason Najum

Industry, Science

23 Aug 2022

A Look at Ketamine Teletherapy

Quite a few psychedelic companies now offer a teletherapy service, But what’s the evidence for the effectiveness of teletherapy using psychedelics?...

By Elisabetta Fato

Industry

23 Aug 2022

Freedom Bio Announces $10.5M Seed Financing For Next-Gen Psychedelics

Freedom Biosciences is a clinical-stage biotechnology platform developing ketamine and psychedelic therapeutics — based on 20 years of Yale University research & Dr....

By Microdose

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result